Recent developments with Unicycive Therapeutics Inc (UNCY) have led to the company’s beta value being reach 2.24 cents.
On Monday, Unicycive Therapeutics Inc (NASDAQ: UNCY) was 4.26% up from the session before settling in for the closing price of $0.53. A 52-week range